Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Adverse Event Trends Associated with Over-the-counter Combination Cold Remedy: Data Mining of the Japanese Adverse Drug Event Report Database].
Sasaoka S, Hatahira H, Hasegawa S, Motooka Y, Fukuda A, Naganuma M, Umetsu R, Nakao S, Shimauchi A, Ueda N, Hirade K, Iguchi K, Nakamura M. Sasaoka S, et al. Among authors: hatahira h. Yakugaku Zasshi. 2018;138(1):123-134. doi: 10.1248/yakushi.17-00172. Yakugaku Zasshi. 2018. PMID: 29311458 Free article. Japanese.
[Evaluation of the Association of Hand-Foot Syndrome with Anticancer Drugs Using the US Food and Drug Administration Adverse Event Reporting System (FAERS) and Japanese Adverse Drug Event Report (JADER) Databases].
Sasaoka S, Matsui T, Abe J, Umetsu R, Kato Y, Ueda N, Hane Y, Motooka Y, Hatahira H, Kinosada Y, Nakamura M. Sasaoka S, et al. Among authors: hatahira h. Yakugaku Zasshi. 2016;136(3):507-15. doi: 10.1248/yakushi.15-00222. Yakugaku Zasshi. 2016. PMID: 26935094 Free article. Japanese.
Age-related trends in injection site reaction incidence induced by the tumor necrosis factor-α (TNF-α) inhibitors etanercept and adalimumab: the Food and Drug Administration adverse event reporting system, 2004-2015.
Matsui T, Umetsu R, Kato Y, Hane Y, Sasaoka S, Motooka Y, Hatahira H, Abe J, Fukuda A, Naganuma M, Kinosada Y, Nakamura M. Matsui T, et al. Among authors: hatahira h. Int J Med Sci. 2017 Jan 15;14(2):102-109. doi: 10.7150/ijms.17025. eCollection 2017. Int J Med Sci. 2017. PMID: 28260984 Free PMC article.
Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system.
Fukuda A, Tahara K, Hane Y, Matsui T, Sasaoka S, Hatahira H, Motooka Y, Hasegawa S, Naganuma M, Abe J, Nakao S, Takeuchi H, Nakamura M. Fukuda A, et al. Among authors: hatahira h. PLoS One. 2017 Sep 27;12(9):e0185654. doi: 10.1371/journal.pone.0185654. eCollection 2017. PLoS One. 2017. PMID: 28953936 Free PMC article.
[Survey of Description on Package Inserts of OTC Drugs].
Shimauchi A, Naganuma M, Sasaoka S, Hatahira H, Motooka Y, Hasegawa S, Fukuda A, Nakao S, Sakai C, Yokoyama S, Ino Y, Nakamura M, Iguchi K. Shimauchi A, et al. Among authors: hatahira h. Yakugaku Zasshi. 2018;138(2):259-267. doi: 10.1248/yakushi.17-00183. Yakugaku Zasshi. 2018. PMID: 29386439 Free article. Japanese.
18 results